Trial Profile
Treatment of Acute Graft vs. [versus] Host Disease With Steroids Plus Daclizumab (Zenapax) or Placebo
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 31 Jan 2017
Price :
$35
*
At a glance
- Drugs Daclizumab (Primary) ; Methylprednisolone; Methylprednisolone
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 19 Jan 2017 Status changed from active, no longer recruiting to completed.
- 06 Jul 2007 New trial record.